CMPX Operating Cash Flow (Statement)
Compass Therapeutics · Operating Cash Flow (Statement)
CMPX Operating Cash Flow (Statement)
Latest reported-$54.79Mperiod ending
CMPX TTM Cash from Operations (-$12.31M → -$54.79M)
TTM operating cash flow (statement)
High-resolution chart · PNG
CMPX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -54,789,000 | |
| -53,204,000 | |
| -49,143,000 | |
| -45,051,000 | |
| -45,253,000 | |
| -44,175,000 | |
| -44,855,000 | |
| -48,047,000 | |
| -42,918,000 | |
| -42,277,000 | |
| -40,618,000 | |
| -38,905,000 | |
| -43,925,000 | |
| -38,412,000 | |
| -34,125,000 | |
| -28,149,000 | |
| -20,664,000 | |
| -22,003,000 | |
| -19,666,000 | |
| -21,574,000 | |
| -25,286,000 | |
| -24,647,000 | |
| -26,803,000 | |
| -25,821,000 | |
| -25,356,000 | |
| -20,064,969 | |
| -12,314,446 | |
| -6,731,340 |